Nutri5® Distribution Product Supply and Marketing Support Agreement

05.12.2008 - Nutri Pharma ASA has today signed a Distribution, Product Supply and Marketing Support Agreement with Nikken UK Ltd. This agreement will give Nikken the exclusive European distribution rights for Nutri5®...

Nutri Pharma ASA has today signed a Distribution, Product Supply and
Marketing Support Agreement with Nikken UK Ltd. This agreement will
give Nikken the exclusive European distribution rights for Nutri5®,
Nutri Pharma`s menopausal health care product, through Nikken`s
direct distribution and sales network.
Nikken will pre-launch Nutri5® to their distributors in Q1 2009, with
sales, initially in 17 European countries, beginning in Q2 2009. The
agreement will also include a transfer of the existing Norwegian
Nutri5® business to Nikken.

About Nikken:
Founded in Japan in 1975, Nikken is one of the largest and most
respected Network Marketing Companies in the world. Nikken has been
at the forefront of the global wellness industry for more than 30
years. Their innovative and exclusive wellness products combine
science, nature and technology to provide Total Wellness Solutions.
They have millions of satisfied customers and are now in more than 35
countries.
The Nikken vision is based on the `Five Pillars of Health` - healthy
body, mind, family, society and finances. They believe that when we
focus on these areas we can achieve a balanced, healthy lifestyle.
And this approach to healthy living is built into everything they do
at Nikken and key to this is the concept of the Wellness Home. The
Nikken Wellness Home® facilitates a balanced life which spans good
water, clean air, restful sleep and proper nutrients.


Anthony Chaplin, CEO Nikken Europe, says:

`Our new partnership with Nutri Pharma ASA presents a unique
opportunity for Nikken.
We feel that the clinical evidence from the years of research carried
out by Nutri Pharma will not only make Nutri5® a good fit with our
existing wellness products, but also enable Nikken to reach out to
new consumers in a new product category.

We intend to make the launch of this new product a priority across
our European markets and look forward to harnessing the experience
and skills of the Nutri Pharma team to assist us in meeting the
challenges ahead`

About Nutri5®:
Nutri5® is a natural soy based nutrition product based on more than
20 years of research and product development carried out by Nutri
Pharma ASA. Nutri5® is a natural alternative to Hormone Replacement
Therapy (HRT), and the composition of its carefully selected natural
soy ingredients has been shown to effectively relieve or stop
menopausal symptoms. Nutri5® has also been documented to
significantly reduce both total and LDL cholesterol and thereby
reduce the risk of heart disease, in addition to the soy components
contributing to the maintenance of normal bone density in
post-menopausal women.


FOR FURTHER INFORMATION:
Trond Syvertsen, CEO +47 23 01 09 60 / + 47 91 72 14 57
Lars Helmer Enger, CFO +47 23 01 09 60 / + 47 90 84 37 71
For information about Nutri Pharma, see; http://www.nutripharma.com
For further information about Nikken, see;
http://www.nikkenwellbeing.co.uk/

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.